Ceinge Biotecnologie Avanzate Franco Salvatore Scarl

Ceinge Biotecnologie Avanzate Franco Salvatore Scarl is an organisation in Napoli, Italy that has taken part in 5 EU-funded projects since 2009, receiving €2.4M in EU funding.

EU funding received€2.4M
EU projects5
As coordinator0
Running now2
First EU project2009
Latest project2022
CountryItaly
EU registration (PIC)999951564
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Ceinge Biotecnologie Avanzate Franco Salvatore Scarl's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.5M · 3 projects
  • Horizon Europe€863k · 1 project
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • OPADEPartner

    Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tool

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €863ktheir share
  • MorphoPHENAssociated partner

    Human Diseases Models Morphological Phenotyping

    Erasmus+ (ERASMUS+) · 2022–2028 · Project on the EU portal ↗

  • HepaMAbPartner

    Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €1.1Mtheir share
  • NUTRITECHPartner

    Application of new technologies and methods in nutrition research – the example of phenotypic flexibility

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €75ktheir share
  • MDDANEURODEVPartner

    Molecular coding and subset specification of dopamine neurons generating the the meso-limbic and nigro-striatal system

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €301ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • developmental biology
  • electrolysis
  • epigenetics
  • genetics
  • hepatitis C
  • hepatology
  • homeostasis
  • immunotherapy
  • microbiology
  • neurobiology
  • nutrition
  • parkinson
  • pathology
  • proteomics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime